Astellas Pharma Inc. (TYO: 4503)
Japan
· Delayed Price · Currency is JPY 1,542.50
+22.50 (1.48%)
Dec 20, 2024, 3:45 PM JST
Astellas Pharma Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 1,772,155 | 1,603,672 | 1,518,619 | 1,296,163 | 1,249,528 | 1,300,843 | Upgrade
|
| Revenue Growth (YoY) | 16.32% | 5.60% | 17.16% | 3.73% | -3.94% | -0.42% | Upgrade
|
| Cost of Revenue | 322,951 | 292,485 | 288,353 | 253,009 | 246,063 | 276,739 | Upgrade
|
| Gross Profit | 1,449,204 | 1,311,187 | 1,230,266 | 1,043,154 | 1,003,465 | 1,024,104 | Upgrade
|
| Selling, General & Admin | 799,059 | 740,110 | 630,272 | 548,840 | 504,316 | 499,295 | Upgrade
|
| Research & Development | 324,570 | 294,187 | 276,128 | 246,010 | 224,489 | 224,226 | Upgrade
|
| Other Operating Expenses | 21,276 | 53,464 | 53,778 | 1,876 | -35 | 11,936 | Upgrade
|
| Operating Expenses | 1,279,223 | 1,186,581 | 998,614 | 825,009 | 752,533 | 756,621 | Upgrade
|
| Operating Income | 169,981 | 124,606 | 231,652 | 218,145 | 250,932 | 267,483 | Upgrade
|
| Interest Expense | -11,977 | -7,423 | -3,217 | -2,315 | -2,118 | -2,232 | Upgrade
|
| Interest & Investment Income | 7,574 | 8,851 | 5,253 | 862 | 760 | 2,248 | Upgrade
|
| Earnings From Equity Investments | -1,479 | -3,165 | 1,260 | 489 | 478 | -1,660 | Upgrade
|
| Currency Exchange Gain (Loss) | -807 | -807 | -10,124 | 8,172 | -2,332 | -8,928 | Upgrade
|
| Other Non Operating Income (Expenses) | -1,721 | -1,723 | 2,303 | -2,431 | 72 | 1,342 | Upgrade
|
| EBT Excluding Unusual Items | 161,571 | 120,339 | 227,127 | 222,922 | 247,792 | 258,253 | Upgrade
|
| Merger & Restructuring Charges | -25,407 | -25,407 | -4,510 | -19,556 | -9,293 | -1,829 | Upgrade
|
| Gain (Loss) on Sale of Investments | -253 | -253 | -5,007 | 5,084 | 10,558 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 1,227 | 9,735 | 212 | 24,234 | 24 | 3,923 | Upgrade
|
| Asset Writedown | -78,931 | -78,931 | -83,964 | -74,850 | -101,746 | -13,796 | Upgrade
|
| Legal Settlements | -514 | -514 | -1,497 | -948 | -2,012 | -1,201 | Upgrade
|
| Pretax Income | 57,693 | 24,969 | 132,361 | 156,886 | 145,323 | 245,350 | Upgrade
|
| Income Tax Expense | 2,947 | 7,924 | 33,647 | 32,800 | 24,734 | 49,939 | Upgrade
|
| Net Income | 54,746 | 17,045 | 98,714 | 124,086 | 120,589 | 195,411 | Upgrade
|
| Net Income to Common | 54,746 | 17,045 | 98,714 | 124,086 | 120,589 | 195,411 | Upgrade
|
| Net Income Growth | 43.73% | -82.73% | -20.45% | 2.90% | -38.29% | -12.08% | Upgrade
|
| Shares Outstanding (Basic) | 1,792 | 1,793 | 1,820 | 1,850 | 1,857 | 1,876 | Upgrade
|
| Shares Outstanding (Diluted) | 1,798 | 1,800 | 1,825 | 1,851 | 1,858 | 1,878 | Upgrade
|
| Shares Change (YoY) | -0.78% | -1.39% | -1.38% | -0.41% | -1.03% | -2.91% | Upgrade
|
| EPS (Basic) | 30.56 | 9.50 | 54.24 | 67.08 | 64.93 | 104.15 | Upgrade
|
| EPS (Diluted) | 30.44 | 9.47 | 54.09 | 67.05 | 64.90 | 104.08 | Upgrade
|
| EPS Growth | 44.81% | -82.49% | -19.33% | 3.31% | -37.64% | -9.45% | Upgrade
|
| Free Cash Flow | 153,203 | 134,419 | 291,326 | 226,705 | 275,459 | 180,731 | Upgrade
|
| Free Cash Flow Per Share | 85.19 | 74.69 | 159.63 | 122.50 | 148.24 | 96.26 | Upgrade
|
| Dividend Per Share | 107.000 | 70.000 | 60.000 | 50.000 | 42.000 | 40.000 | Upgrade
|
| Dividend Growth | 256.67% | 16.67% | 20.00% | 19.05% | 5.00% | 5.26% | Upgrade
|
| Gross Margin | 81.78% | 81.76% | 81.01% | 80.48% | 80.31% | 78.73% | Upgrade
|
| Operating Margin | 9.59% | 7.77% | 15.25% | 16.83% | 20.08% | 20.56% | Upgrade
|
| Profit Margin | 3.09% | 1.06% | 6.50% | 9.57% | 9.65% | 15.02% | Upgrade
|
| Free Cash Flow Margin | 8.65% | 8.38% | 19.18% | 17.49% | 22.05% | 13.89% | Upgrade
|
| EBITDA | 365,893 | 282,446 | 337,390 | 297,829 | 323,584 | 333,879 | Upgrade
|
| EBITDA Margin | 20.65% | 17.61% | 22.22% | 22.98% | 25.90% | 25.67% | Upgrade
|
| D&A For EBITDA | 195,912 | 157,840 | 105,738 | 79,684 | 72,652 | 66,396 | Upgrade
|
| EBIT | 169,981 | 124,606 | 231,652 | 218,145 | 250,932 | 267,483 | Upgrade
|
| EBIT Margin | 9.59% | 7.77% | 15.25% | 16.83% | 20.08% | 20.56% | Upgrade
|
| Effective Tax Rate | 5.11% | 31.74% | 25.42% | 20.91% | 17.02% | 20.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.